e-learning
resources
Stockholm 2007
Monday 17.09.2007
Ethical and economic choices in respiratory care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cost-effectiveness of varenicline for smoking cessation in the Netherlands
M. Hoogendoorn, M. Rutten-van Mölken (Rotterdam, Netherlands)
Source:
Annual Congress 2007 - Ethical and economic choices in respiratory care
Session:
Ethical and economic choices in respiratory care
Session type:
Oral Presentation
Number:
1583
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Hoogendoorn, M. Rutten-van Mölken (Rotterdam, Netherlands). Cost-effectiveness of varenicline for smoking cessation in the Netherlands. Eur Respir J 2007; 30: Suppl. 51, 1583
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Effectiveness of varenicline treatment in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009
Cost-effectiveness of 5 smoking cessation interventions
Source: Eur Respir J 2004; 24: Suppl. 48, 463s
Year: 2004
Costs and benefits accruing from smoking cessation with varenicline
Source: Annual Congress 2007 - Smoking cessation
Year: 2007
Causes of quitting treatment with varenicline in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009
Efficacy of bupropion therapy in smoking cessation
Source: Eur Respir J 2004; 24: Suppl. 48, 153s
Year: 2004
Cost effectiveness of retreatment with varenicline compared to other commonly used smoking cessation interventions
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015
Effectiveness and cost-effectiveness of smoking cessation interventions
Source: International Congress 2015 – New advances in smoking cessation interventions
Year: 2015
The impact and costs of reimbursed smoking cessation using varenicline in Denmark
Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine
Year: 2010
Medical treatment effectiveness in smoking cessation
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017
The costs of smoking and the economics of smoking cessation
Source: Eur Respir Mon; 2008: 42: 23–34
Year: 2008
Improvement of quit smoking rate by combining varenicline and nicotine replacement therapy
Source: Annual Congress 2009 - Smoking cessation
Year: 2009
Effectiveness of treatment with bupropion HCL, NRTs and combination in smoking cessation
Source: Eur Respir J 2004; 24: Suppl. 48, 156s
Year: 2004
Comparison of efficacy of varenicline and nortriptyline– Short-term smoking cessation in outpatient setting
Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products
Year: 2016
Efficacy of bupropion SR in a smoking cessation programme for heavy smokers: preliminary results
Source: Eur Respir J 2001; 18: Suppl. 33, 167s
Year: 2001
Annual budgetary impact of varenicline as part of a smoking cessation strategy in Greece
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015
Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008
e-cigarettes for smoking cessation
Source: International Congress 2015 – E-cigarettes: a wolf in sheep's clothing or a sheep in wolf's clothing?
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept